The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
Open accessAbstract
Antimicrobial peptides (AMPs), or host defense peptides, are small cationic or amphipathic molecules produced by prokaryotic and eukaryotic organisms that play a key role in the innate immune defense against viruses, bacteria and fungi. AMPs have either antimicrobial or anticancer activities. Indeed, cationic AMPs are able to disrupt microbial cell membranes by interacting with negatively charged phospholipids. Moreover, several peptides are capable to trigger cytotoxicity of human cancer cells by binding to negatively charged phosphatidylserine moieties which are selectively exposed on the outer surface of cancer cell plasma membranes. In addition, some AMPs, such as LTX-315, have shown to induce release of tumor antigens and potent damage associated molecular patterns by causing alterations in the intracellular organelles of cancer cells. Given the recognized medical need of novel anticancer drugs, AMPs could represent a potential source of effective therapeutic agents, either alone or in combination with other small molecules, in oncology. In this review we summarize and describe the properties and the mode of action of AMPs as well as the strategies to increase their selectivity toward specific cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Drug resistance in cancer: An overview
Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N., & Sarkar, S. (2014) · Cancers · doi:10.3390/cancers6031769 · Cited by 2,463
APD3: the antimicrobial peptide database as a tool for research and education
Wang, G., Li, X., & Wang, Z. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1278 · Cited by 2,388
Shai, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00200-x · Cited by 1,869
Nanoparticle Delivery of Cancer Drugs
Wang, A. Z., Langer, R., & Farokhzad, O. C. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-040210-162544 · Cited by 1,561
The antimicrobial peptides and their potential clinical applications.
Lei, J., Sun, L., Huang, S., Zhu, C., Li, P., He, J., Mackey, V., Coy, D. H., & He, Q. (2019) · PubMed · Cited by 1,429
Defensins. Natural peptide antibiotics of human neutrophils.
Ganz, T., Selsted, M. E., Szklarek, D., Harwig, S. S., Daher, K., Bainton, D. F., & Lehrer, R. I. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112120 · Cited by 1,416
Lipid metabolic reprogramming in cancer cells
Beloribi-Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,398
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
Cationic peptides: a new source of antibiotics
Hancock, R. E. W., & Lehrer, R. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01156-6 · Cited by 1,336
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190
Hancock, R. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,096
The transient receptor potential family of ion channels
Nilius, B., & Owsianik, G. (2011) · Genome Biology · doi:10.1186/gb-2011-12-3-218 · Cited by 919
Identification of the bactericidal domain of lactoferrin
Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K., & Tomita, M. (1992) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(92)90346-f · Cited by 892
VDAC, a multi-functional mitochondrial protein regulating cell life and death
Shoshan-Barmatz, V., De Pinto, V., Zweckstetter, M., Raviv, Z., Keinan, N., & Arbel, N. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.03.002 · Cited by 782
From antimicrobial to anticancer peptides. A review
Gaspar, D., Veiga, A. S., & Castanho, M. A. R. B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00294 · Cited by 749
CAMP R3 : a database on sequences, structures and signatures of antimicrobial peptides: Table 1.
Waghu, F. H., Barai, R. S., Gurung, P., & Idicula-Thomas, S. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1051 · Cited by 715
Role of lipids in the interaction of antimicrobial peptides with membranes
Teixeira, V., Feio, M. J., & Bastos, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.005 · Cited by 692
The Roles of Antimicrobial Peptides in Innate Host Defense
Diamond, G., Beckloff, N., Weinberg, A., & Kisich, K. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682325 · Cited by 642
Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces
Costa, F., Carvalho, I. F., Montelaro, R. C., Gomes, P., & Martins, M. C. L. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.11.005 · Cited by 627
Antimicrobial peptides: an overview of a promising class of therapeutics
Giuliani, A., Pirri, G., & Nicoletto, S. (2007) · Open Life Sciences · doi:10.2478/s11535-007-0010-5 · Cited by 606
Antimicrobial peptides: General overview and clinical implications in human health and disease
Guaní-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S. O., & Terán, L. M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.004 · Cited by 549
Increased exposure of anionic phospholipids on the surface of tumor blood vessels.
Ran, S., Downes, A., & Thorpe, P. E. (2002) · PubMed · Cited by 471
Lehrer, R. I. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro976 · Cited by 448
A cathelicidin family of human antibacterial peptide LL‐37 induces mast cell chemotaxis
Niyonsaba, F., Iwabuchi, K., Someya, A., Hirata, M., Matsuda, H., Ogawa, H., & Nagaoka, I. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01398.x · Cited by 402
CancerPPD: a database of anticancer peptides and proteins
Tyagi, A., Tuknait, A., Anand, P., Gupta, S., Sharma, M., Mathur, D., Joshi, A., Singh, S., Gautam, A., & Raghava, G. P. S. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku892 · Cited by 397
Peptides with Dual Antimicrobial and Anticancer Activities
Felício, M. R., Silva, O. N., Gonçalves, S., Santos, N. C., & Franco, O. L. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00005 · Cited by 393
DRAMP 2.0, an updated data repository of antimicrobial peptides
Kang, X., Dong, F., Shi, C., Liu, S., Sun, J., Chen, J., Li, H., Xu, H., Lao, X., & Zheng, H. (2019) · Scientific Data · doi:10.1038/s41597-019-0154-y · Cited by 393
Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications
Deslouches, B., & Di, Y. P. (2017) · Oncotarget · doi:10.18632/oncotarget.16743 · Cited by 390
Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions
Raheem, N., & Straus, S. K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02866 · Cited by 369
The human cathelicidin LL-37 — A pore-forming antibacterial peptide and host-cell modulator
Xhindoli, D., Pacor, S., Benincasa, M., Scocchi, M., Gennaro, R., & Tossi, A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.11.003 · Cited by 366
STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS
Dubos, R. J. (1939) · The Journal of Experimental Medicine · doi:10.1084/jem.70.1.1 · Cited by 358
Sitaram, N., & Nagaraj, R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00199-6 · Cited by 353
Cell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like Particles
Ashley, C. E., Carnes, E. C., Phillips, G. K., Durfee, P. N., Buley, M. D., Lino, C. A., Padilla, D. P., Phillips, B., Carter, M. B., Willman, C. L., et al. (2011) · ACS Nano · doi:10.1021/nn201397z · Cited by 350
In vitro and In vivo Wound Healing-Promoting Activities of Human Cathelicidin LL-37
Carretero, M., Escámez, M. J., García, M., Duarte, B., Holguín, A., Retamosa, L., Jorcano, J. L., Río, M. D., & Larcher, F. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701043 · Cited by 345
Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs
Nguyen, L. T., Chau, J. K., Perry, N. A., de Boer, L., Zaat, S. A. J., & Vogel, H. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012684 · Cited by 333
PHAGOCYTIN: A BACTERICIDAL SUBSTANCE FROM POLYMORPHONUCLEAR LEUCOCYTES
Hirsch, J. G. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.103.5.589 · Cited by 325
Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents
Borrelli, A., Tornesello, A., Tornesello, M., & Buonaguro, F. (2018) · Molecules · doi:10.3390/molecules23020295 · Cited by 295
Self-citationAll‐D‐magainin: chirality, antimicrobial activity and proteolytic resistance
(1990) · FEBS Letters · doi:10.1016/0014-5793(90)81351-n · Cited by 294
Farkhani, S. M., Valizadeh, A., Karami, H., Mohammadi, S., Sohrabi, N., & Badrzadeh, F. (2014) · Peptides · doi:10.1016/j.peptides.2014.04.015 · Cited by 273
Qureshi, A., Thakur, N., Tandon, H., & Kumar, M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1191 · Cited by 271
A proapoptotic peptide for the treatment of solid tumors.
Mai, J., Mi, Z., Kim, S.-H., Ng, B., & Robbins, P. D. (2001) · PubMed · Cited by 247
Defensins: A Double-Edged Sword in Host Immunity
Xu, D., & Lu, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00764 · Cited by 242
Ashley, C. E., Carnes, E. C., Epler, K. E., Padilla, D. P., Phillips, G. K., Castillo, R. E., Wilkinson, D. C., Wilkinson, B. S., Burgard, C. A., Kalinich, R. M., et al. (2012) · ACS Nano · doi:10.1021/nn204102q · Cited by 239
Frank, M. G., Weber, M. D., Watkins, L. R., & Maier, S. F. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.010 · Cited by 237
Anticancer efficacy of Magainin2 and analogue peptides.
Baker, M. A., Maloy, W. L., Zasloff, M., & Jacob, L. S. (1993) · PubMed · Cited by 236
Antitumor Activity of the Antimicrobial Peptide Magainin II against Bladder Cancer Cell Lines
Lehmann, J., Retz, M., Sidhu, S. S., Suttmann, H., Sell, M., Paulsen, F., Harder, J., Unteregger, G., & Stöckle, M. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.043 · Cited by 228
Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging
Ebenhan, T., Gheysens, O., Kruger, H. G., Zeevaart, J. R., & Sathekge, M. M. (2014) · BioMed Research International · doi:10.1155/2014/867381 · Cited by 225
Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria
Scocchi, M., Mardirossian, M., Runti, G., & Benincasa, M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150703121009 · Cited by 225
The interaction of antimicrobial peptides with membranes
Travkova, O. G., Moehwald, H., & Brezesinski, G. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.06.001 · Cited by 220
Human Antimicrobial Peptides as Therapeutics for Viral Infections
Ahmed, A., Siman-Tov, G., Hall, G., Bhalla, N., & Narayanan, A. (2019) · Viruses · doi:10.3390/v11080704 · Cited by 220
Crystal structures of human α‐defensins HNP4, HD5, and HD6
Szyk, A., Wu, Z., Tucker, K., Yang, D., Lu, W., & Lubkowski, J. (2006) · Protein Science · doi:10.1110/ps.062336606 · Cited by 214
El Boustany, C., Bidaux, G., Enfissi, A., Delcourt, P., Prevarskaya, N., & Capiod, T. (2008) · Hepatology · doi:10.1002/hep.22263 · Cited by 210
Antibacterial and Enzymic Basic Proteins from Leukocyte Lysosomes: Separation and Identification
Zeya, H. I., & Spitznagel, J. K. (1963) · Science · doi:10.1126/science.142.3595.1085 · Cited by 210
Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide
Lee, H. S., Park, C. B., Kim, J. M., Jang, S. A., Park, I. Y., Kim, M. S., Cho, J. H., & Kim, S. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.041 · Cited by 188
Improved Methods for Classification, Prediction, and Design of Antimicrobial Peptides
Wang, G. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2285-7_3 · Cited by 187
Eliassen, L. T., Berge, G., Leknessund, A., Wikman, M., Lindin, I., Løkke, C., Ponthan, F., Johnsen, J. I., Sveinbjørnsson, B., Kogner, P., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21886 · Cited by 181
Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery
Lo, A., Lin, C.-T., & Wu, H.-C. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2359 · Cited by 179
Ghavami, S., Asoodeh, A., Klonisch, T., Halayko, A. J., Kadkhoda, K., Kroczak, T. J., Gibson, S. B., Booy, E. P., Naderi‐Manesh, H., & Los, M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00129.x · Cited by 171
Ren, S. X., Cheng, A. S. L., To, K. F., TONG, J. H. M., Li, M. S. M., Shen, J. S., Wong, C. C. M., Zhang, L., Chan, R. L. Y., Wang, X., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2359 · Cited by 163
Advances in Lipid and Metal Nanoparticles for Antimicrobial Peptide Delivery
Makowski, M., Silva, Í. C., do Amaral, C. P., Gonçalves, S., & Santos, N. C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110588 · Cited by 159
Pazos, E., Sleep, E., Pérez, C. M. R., Lee, S. S., Tantakitti, F., & Stupp, S. I. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b01570 · Cited by 156
Seebah, S., Suresh, A., Zhuo, S., Choong, Y. H., Chua, H., Chuon, D., Beuerman, R. W., & Verma, C. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl866 · Cited by 148
Okumura, K., Itoh, A., Isogai, E., Hirose, K., Hosokawa, Y., Abiko, Y., Shibata, T., Hirata, M., & Isogai, H. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.04.006 · Cited by 147
Chavakis, T., Cines, D. B., Rhee, J.-S., Liang, O. D., Schubert, U., Hammes, H., Higazi, A. A., Nawroth, P. P., Preissner, K. T., & Bdeir, K. (2004) · The FASEB Journal · doi:10.1096/fj.03-1009fje · Cited by 145
Bevers, E. M., Comfurius, P., & Zwaal, R. F. A. (1996) · Lupus · doi:10.1177/096120339600500531 · Cited by 143
Roudi, R., Syn, N. L., & Roudbary, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01320 · Cited by 139
Papo, N., Seger, D., Makovitzki, A., Kalchenko, V., Eshhar, Z., Degani, H., & Shai, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4569 · Cited by 139
Rene Dubos: unearthing antibiotics
Epps, H. L. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.2032fta · Cited by 137
Baxter, A. A., Lay, F. T., Poon, I. K. H., Kvansakul, M., & Hulett, M. D. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2604-z · Cited by 131
D-amino acid substitution enhances the stability of antimicrobial peptide polybia-CP
Jia, F., Wang, J., Peng, J., Zhao, P., Kong, Z., Wang, K., Yan, W., & Wang, R. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx091 · Cited by 127
Induction of non-lamellar lipid phases by antimicrobial peptides: a potential link to mode of action
Haney, E. F., Nathoo, S., Vogel, H. J., & Prenner, E. J. (2009) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2009.09.002 · Cited by 122
Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide
Haug, B. E., Camilio, K. A., Eliassen, L. T., Stensen, W., Svendsen, J. S. M., Berg, K., Mortensen, B., Serin, G., Mirjolet, J.-F., Bichat, F., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b02025 · Cited by 122
A New Hope: Self-Assembling Peptides with Antimicrobial Activity
Lombardi, L., Falanga, A., Genio, V. D., & Galdiero, S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11040166 · Cited by 119
Antimicrobial Peptides: Potential Application in Liver Cancer
Zhang, C., Yang, M. J., & Ericsson, A. C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01257 · Cited by 111
Savini, F., Loffredo, M. R., Troiano, C., Bobone, S., Malanović, N., Eichmann, T. O., Caprio, L. D., Canale, V. C., Park, Y., Mangoni, M. L., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183291 · Cited by 110
Chuang, C.-M., Monie, A., Wu, A. A., Mao, C.-P., & Hung, C. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.124 · Cited by 108
Selectivity of Antimicrobial Peptides: A Complex Interplay of Multiple Equilibria
Bobone, S., & Stella, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3588-4_11 · Cited by 105
A common landscape for membrane‐active peptides
Last, N. B., Schlamadinger, D. E., & Miranker, A. D. (2013) · Protein Science · doi:10.1002/pro.2274 · Cited by 101
Chemical Tumor Biology of Heparan Sulfate Proteoglycans
Raman, K., & Kuberan, B. (2010) · Current Chemical Biology · doi:10.2174/187231310790226206 · Cited by 97
Mehta, D., Anand, P., Kumar, V. D., Joshi, A., Mathur, D. D., Singh, S., Tuknait, A., Chaudhary, K., Gautam, S. K., Gautam, A., et al. (2014) · Database · doi:10.1093/database/bau051 · Cited by 97
Human antimicrobial peptides and cancer
Jin, G., & Weinberg, A. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.04.006 · Cited by 96
Oligomerization of the Mitochondrial Protein VDAC1
Shoshan‐Barmatz, V., Mizrachi, D., & Keinan, N. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386931-9.00011-8 · Cited by 94
LTX-315: A First-In-Class Oncolytic Peptide that Reprograms the Tumor Microenvironment
Sveinbj�rnsson, B., Camilio, K. A., Haug, B. E., & Rekdal, Ø. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0088 · Cited by 91
Shang, D., Zhang, Q., Dong, W., Liang, H., & Bi, X. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.01.019 · Cited by 89
Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
Tornesello, A. L., Tagliamonte, M., Tornesello, M. L., Buonaguro, F. M., & Buonaguro, L. (2020) · Cancers · doi:10.3390/cancers12041049 · Cited by 87
Self-citationTargeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide
Pittala, S., Krelin, Y., & Shoshan‐Barmatz, V. (2018) · Neoplasia · doi:10.1016/j.neo.2018.02.012 · Cited by 86
Mader, J. S., Mookherjee, N., Hancock, R. E. W., & Bleackley, R. C. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0274 · Cited by 85
Niemirowicz, K., Prokop, I., Wilczewska, A. Z., Wnorowska, U., Piktel, E., Wątek, M., Savage, P. B., & Bucki, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s76104 · Cited by 82
de Azevedo, R. A., Figueiredo, C. R., Ferreira, A. K., Matsuo, A. L., Massaoka, M. H., Girola, N., Auada, A. V. V., Farias, C. F., Pasqualoto, K. F. M., Rodrigues, C. P., et al. (2014) · Peptides · doi:10.1016/j.peptides.2014.09.024 · Cited by 81
Structure and function of a custom anticancer peptide, CB1a
Wu, J.-M., Jan, P.-S., Yu, H.-C., Haung, H.-Y., Fang, H., Chang, Y., Cheng, J.-W., & Chen, H. M. (2009) · Peptides · doi:10.1016/j.peptides.2009.02.004 · Cited by 79
Rational Design of Alpha‐Helical Antimicrobial Peptides: Do's and Don'ts
Uggerhøj, L. E., Poulsen, T. J., Munk, J. K., Fredborg, M., Søndergaard, T. E., Frimodt‐Møller, N., Hansen, P. B., & Wimmer, R. (2014) · ChemBioChem · doi:10.1002/cbic.201402581 · Cited by 78
Liu, S., Yang, H., Wan, L., Cai, H., Li, S., Li, Y., Cheng, J., & Lu, X. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.162 · Cited by 76
Domingues, T. M., Riske, K. A., & Miranda, A. (2010) · Langmuir · doi:10.1021/la100662a · Cited by 75
Kudrimoti, M. R., Amarintha, C., Azawi, S., Worden, F. P., Katz, S. R., Adkins, D., Bonomi, M. R., Elder, J., Sonis, S. T., Straube, R., et al. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.10.010 · Cited by 74
Piotrowska, U., Sobczak, M., & Olędzka, E. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13031 · Cited by 73
Bartels, E. J. H., Dekker, D., & Amiche, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01421 · Cited by 73
Human α-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice
Xu, N., Wang, Y., Pan, W., Xiao, B., Wen, Y., Chen, X., Chen, L., Deng, H., You, J., Kan, B., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0010 · Cited by 71
Xhindoli, D., Pacor, S., Guida, F., Antcheva, N., & Tossi, A. (2013) · Biochemical Journal · doi:10.1042/bj20131048 · Cited by 69
Antimicrobial peptides as novel therapeutics for non-small cell lung cancer
Kunda, N. K. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.11.012 · Cited by 68
Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide
Liu, B. H., Jobichen, C., Chia, C. S. B., Chan, T. H. M., Tang, J. P., Chung, T. X. Y., Li, J., Poulsen, A., Hung, A. W., Koh-Stenta, X., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801253115 · Cited by 67
Wodlej, C., Riedl, S., Rinner, B., Leber, R., Drechsler, C., Voelker, D. R., Choi, J., Lohner, K., & Zweytick, D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211187 · Cited by 66
Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice
Wang, Y., Li, D., Shi, H., Wen, Y., Yang, L., Xu, N., Chen, X., Chen, X., Chen, P., Li, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0484 · Cited by 65
Mao, J., Liu, S., Ai, M., Wang, Z., Wang, D., Li, X., Hu, K., Gao, X., & Yang, Y. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0442-y · Cited by 65
Gkeka, P., & Sarkisov, L. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp908320b · Cited by 62
Phan, T. K., Lay, F. T., Poon, I. K. H., Hinds, M. G., Kvansakul, M., & Hulett, M. D. (2015) · Oncotarget · doi:10.18632/oncotarget.6520 · Cited by 61
Antimicrobial peptide LL-37 attenuates LTA induced inflammatory effect in macrophages
Ruan, Y., Shen, T., Wang, Y., Hou, M., Li, J., & Sun, T. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.01.012 · Cited by 60
Hepatocellular carcinoma-targeted nanoparticles for cancer therapy
Wu, C., Lan, C.-H., Wu, K., Wu, Y., Jane, W., Hsiao, M., & Wu, H. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4205 · Cited by 53
Engineered Apoptosis-Inducing Peptides with Enhanced Mitochondrial Localization and Potency
Horton, K. L., & Kelley, S. O. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900178n · Cited by 45
Cathelicidin suppresses colon cancer development by inhibition of cancer associated fibroblasts
Koon, H. W., Cheng, M., Ho, S., Yoo, J. H., Bakirtzi, K., Tran, D. H., Su, B., Tran, D., Ichikawa, R., & Kubota, Y. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s70906 · Cited by 44
Defensins at the Mucosal Surface: Latest Insights into Defensin-Virus Interactions
Wilson, S. S., Wiens, M. E., Holly, M. K., & Smith, J. G. (2016) · Journal of Virology · doi:10.1128/jvi.00904-15 · Cited by 44
Hansen, I. K. Ø., Isaksson, J. M., Poth, A. G., Hansen, K. Ø., Andersen, A. J. C., Richard, C. S. M., Blencke, H., Stensvåg, K., Craik, D. J., & Haug, T. (2020) · Marine Drugs · doi:10.3390/md18010051 · Cited by 43
Santos, C. D., Hamadat, S., Saux, K. L., Newton, C., Mazouni, M., Zargarian, L., Miro-Padovani, M., Zadigue, P., Delbé, J., Hamma‐Kourbali, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182926 · Cited by 42
Spinks, C., Zidan, A. S., Khan, M. A., Habib, M. J., & Faustino, P. J. (2017) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s119875 · Cited by 41
Chen, X., Zhang, L., Ma, C., Zhang, Y., Xi, X., Wang, L., Zhou, M., Burrows, J. F., & Chen, T. (2018) · Bioscience Reports · doi:10.1042/bsr20180710 · Cited by 41
Hsu, J.-C., Lin, L.-C., Tzen, J. T. C., & Chen, J. (2011) · Peptides · doi:10.1016/j.peptides.2011.02.013 · Cited by 39
Domalaon, R., Findlay, B., Ogunsina, M. O., Arthur, G., & Schweizer, F. (2016) · Peptides · doi:10.1016/j.peptides.2016.07.007 · Cited by 39
Kelly, G., Kia, A. F.-A., Hassan, F., O’Grady, S., Morgan, M. P., Creaven, B. S., McClean, S., Harmey, J. H., & Devocelle, M. C. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob01815g · Cited by 37
Chen, Y. S., Li, J., Yu, C., Lin, C., Chiu, P.-H., Chen, P., Lin, C.-C., & Chen, W. (2012) · Peptides · doi:10.1016/j.peptides.2012.05.011 · Cited by 36
Xia, L., Wu, Y., MA, J., Yang, J., & Zhang, F. (2016) · Oncology Letters · doi:10.3892/ol.2016.4601 · Cited by 34
Efficacy of a proapoptotic peptide towards cancer cells.
Jäkel, C. E., Meschenmoser, K., Kim, Y., Weiher, H., & Schmidt‐Wolf, I. G. H. (2012) · PubMed · Cited by 33
Li, B., Lyu, P., Xie, S., Qin, H., Pu, W., Xu, H., Chen, T., Shaw, C., Ge, L., & Kwok, H. F. (2019) · Biomolecules · doi:10.3390/biom9060242 · Cited by 33
Selective Inhibition of Liver Cancer Cells Using Venom Peptide
Anand, P., Filipenko, P., Huaman, J., Lyudmer, M., Hossain, M., Santamaria, C., Huang, K., Ogunwobi, O. O., & Holford, M. (2019) · Marine Drugs · doi:10.3390/md17100587 · Cited by 32
Anju, A., Smitha, C. K., Preetha, K., Rangaswamy, B., & Philip, R. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.03.007 · Cited by 31
Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6+CD4+ T Cells
Lafferty, M. K., Sun, L., Christensen-Quick, A., Lu, W., & Demo, A. G. (2017) · Viruses · doi:10.3390/v9050111 · Cited by 30
Bouchet, S., Tang, R., Fava, F., Legrand, O., & Bauvois, B. (2015) · Oncotarget · doi:10.18632/oncotarget.6523 · Cited by 29
gH625-liposomes as tool for pituitary adenylate cyclase-activating polypeptide brain delivery
Iachetta, G., Falanga, A., Molino, Y., Masse, M., Jabès, F., Mechioukhi, Y., Laforgia, V., Khrestchatisky, M., Galdiero, S., & Valiante, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-45137-8 · Cited by 29
Dermaseptins as potential antirabies compounds
Mechlia, M. B., Belaïd, A., Castel, G., Jallet, C., Mansfield, K. L., Fooks, A. R., Hani, K., & Tordo, N. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.066 · Cited by 28
Bacteriophages Displaying Anticancer Peptides in Combined Antibacterial and Anticancer Treatment
Dąbrowska, K., Kaźmierczak, Z. M., Majewska, J., Miernikiewicz, P., Piotrowicz, A., Wietrzyk, J., Lecion, D., Hodyra‐Stefaniak, K., Nasulewicz‐Goldeman, A., Owczarek, B., et al. (2014) · Future Microbiology · doi:10.2217/fmb.14.50 · Cited by 25
D-K6L9 Peptide Combination with IL-12 Inhibits the Recurrence of Tumors in Mice
Cichoń, T., Smolarczyk, R., Matuszczak, S., Barczyk, M., Jarosz–Biej, M., & Szala, S. (2014) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-014-0268-z · Cited by 23
The Anticancer Peptide TAT-RasGAP317−326 Exerts Broad Antimicrobial Activity
Heulot, M., Jacquier, N., Aeby, S., Roy, D. L., Roger, T., Trofimenko, E., Barras, D., Greub, G., & Widmann, C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00994 · Cited by 23
Li, H., Yuan, D., Sun, M., & Ping, Q. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1209797 · Cited by 21
Kudrimoti, M. R., Curtis, A. E., Azawi, S., Worden, F. P., Katz, S. R., Adkins, D. R., Bonomi, M. R., Scott, Z., Elder, J., Sonis, S. T., et al. (2017) · Biotechnology Reports · doi:10.1016/j.btre.2017.05.002 · Cited by 21
Membranotropic peptides mediating viral entry
Falanga, A., Galdiero, M., Morelli, G., & Galdiero, S. (2018) · Peptide Science · doi:10.1002/pep2.24040 · Cited by 16
Highly chemoselective ligation of thiol- and amino-peptides on a bromomaleimide core
Ramesh, S., Cherkupally, P., Govender, T., Kruger, H. G., Alberício, F., & de la Torre, B. G. (2015) · Chemical Communications · doi:10.1039/c5cc09457g · Cited by 10
Bahmani, T., Sharifzadeh, S., Tamaddon, G., Farzadfard, E., Zare, F., Fadaie, M., Alizadeh, M., Hadi, M., Ranjbaran, R., Mosleh‐Shirazi, M. A., et al. (2019) · Journal of Biomedical Physics and Engineering · doi:10.31661/jbpe.v0i0.905 · Cited by 9
A novel anti-adhesion peptide (β3) inhibits hepatocellular carcinoma activity in vitro and in vivo
Wang, S., Zhu, J., & Liu, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.5277 · Cited by 7
Cited by
Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.007 · Cited by 1,834
Mechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities
Luo, Y., & Song, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111401 · Cited by 559
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Melero, I., Castanon, E., Alvarez, M., Champiat, S., & Marabelle, A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00507-y · Cited by 493
Antimicrobial peptides towards clinical application: Delivery and formulation
Wang, C., Hong, T., Cui, P., Wang, J., & Xia, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.028 · Cited by 281
Qazi, H. J., Ye, A., Acevedo-Fani, A., & Singh, H. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2353366 · Cited by 54
“…been reported to have several health-promoting activities such as antimicrobial, antioxidant, anti-inflammatory, antidiabetic, among others (Eggersdorfer and Wyss 2018; Oyenihi and Smith 2019; Prasad et al. 2022; Ruhee et al. 2020; Szewczyk, Chojnacka, and Górnicka 2021; Tornesello et al. 2020).”
Metadata
- Authors
- Tornesello, A. L., Borrelli, A., Buonaguro, L., Buonaguro, F. M., & Tornesello, M. L.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-06-19
- Volume
- 25
- Issue
- 12
- Pages
- 2850
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W3036713553
- Cited by
- 383
- References
- 138
- FWCI
- 26.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.